EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.
Issue link: https://digital.eyeworld.org/i/307230
The rst objective and quantitative measurement of Dry Eye Disease The TearLab ® Osmolarity System delivers fast and accurate results in seconds using only a 50nL tear sample to diagnose Dry Eye Disease. * Incorporating osmolarity into the standard of care gives the best indication of early stage disease. And TearLab enables discussion with patients around a number they can relate to, improving compliance. 335 MANAGE DRY EYE WITH CONFIDENCE For more information call 1-855-TearLab (832-7522) or visit us online @ www.tearlab.com. In Canada call 1-905-486-1163 ©2011 TearLab Corp. *The TearLab Osmolarity System is intended to measure the osmolarity of human tears to aid in the diagnosis of Dry Eye Disease in patients suspected of having Dry Eye Disease, in conjunction with other methods of clinical evaluation. 920049 REV A FDA 510(K) CLEARED (K083184) r TearLab is designated as CLIA Moderately Complex. What's Your Number? e v i t c e j b o t s r e h T u s a e m e v i t a t i t n a u q d n a e e s i D e y E y r D f o t n e m e r u e s a e i t a p h t i w n o i s s u c s i d s e v i g e r a c f o d r a d n a t s o t e l p m a s r a e t L n 0 5 a r a l o m s O ® b a L r a e Te e h T c n o i t a m r o fo n i e r o m r o F 0 1 5 A D F a c y e h t r e b m u n a d n u o r a s t n s y l r a e f o n o i t a c i d n i t s e b e h t s * . e s a e s i D e y E y r D e s o n g a i d o c a d n a t s a fa s r e v i l e d m e t s y S y t i r o ) 2) 2 5 7 - 2 3 8 (8 b a L rL a e Te - 5 5 8 - 1 l l a e T r ) 4 8 1 3 8 0 K ( D E R A E L C ) K) ( 0 p m o c g n i v o r p m i , o t e t a l e r n a n e b a L r a e Te d n A . e s a e s i d e g a t s t n i y t i r a l o m s o g n i t a r o p r o c n I * n i s u s d n o c e s n i s t l u s e r e t a r u c c o c . b a l rl a e t . w w w @ e n i l n o s u t i s i v M A I L C s a d e t a n g i s e d s i b a L r a e . e c n a i l s e l b a n e h t o t y l n o g 1 - 6 8 4 - 5 0 9 - 1 l l a c a d a n a C n I . m o . x e l p m o C y l e t a r e d o M 3 6 1 1 t c e p s u s s t n e i t a p n i o m s O b a L r a e T e h T * m r e h t o h t i w n o i t c n u j nj o c n i , e s a e s i D e y E y r D g n i v a h f o d e u h f o y t i r a l o m s o e h t e r u s a e m o t d e d n e t n i s i m e t s y S y t i r a l o . n o i t a u l a v e l a c i n i l c f o s d o h t e m e s a e s i D e y E y r D f o s i s o n g a i d e h t n i d i a o t s r a e t n a m u . p r o C b a L r a e T 1 1 0 2 © 4 0 0 2 9 A V E R 9 032-047 Feature_EW April 2011-DL_Layout 1 4/10/11 8:01 AM Page 41